Developping Strategic Partnerships
ReadyCell counts on a wide range of strategic partners with which the company has developed strong and long-lasting strategic partnerships. This consists in collaboration, joint initiatives, common projects and more.
Leitat is a private technical institute with more than 110 years of experience in industrial innovation processes. It transforms technological and scientific results into economic and competitive value for our clients and collaborating entities. Over 1500 customers benefit from our talent, creativity and strong commitment. It brings knowledge and innovation to our customers through applied research and technical testing in the fields of chemistry, energy, environment, materials, engineering and life sciences. It relies upon our 240 highly skilled team members who deliver flexible solutions to face any industrial challenge.
ACCIÓ is the public agency for the competitiveness of the Catalan government. Its objective is to boost the competitiveness and growth of the Catalan businesses through the promotion of innovation, business internationalization and the attraction of investments. It is responsible for attracting foreign investments to Catalonia, a task that is carried out through the Catalonia Trade & Investment area, which is specifically responsible for promoting Catalonia as an attractive, innovative and competitive area for foreign companies. The agency accompanies and advises foreign companies during all phases of their projects, when looking for partners, the most competitive suppliers or the technology they need to establish in Catalonia. Currently, ACCIÓ accounts with a network of 40 foreign offices worldwide and seven branches throughout Catalonia. It collaborates with local and international business entities to add synergies and ensure that the Catalan company has a broader range of tools to grow in competitiveness.
The Netherlands Cancer Institute was established on October 10, 1913. The founders wanted to create a cancer institute ‘where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied’. Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.